Observational Study to Evaluate the Actual Use and Effectiveness of Dymista® Nasal Spray in Asian Patients

Allergic Rhinitis Clinical Trial

Official title: Observational Study to Evaluate the Actual Use and Effectiveness of Dymista® Nasal Spray in Asian Patients

Status Completed

Clinical Trial Summary

Gathering knowledge on the use of Dymista® in Asian patients who receive Dymista® for the first time in routine clinical practice

Clinical Trial Description

A) Primary objective:

Gathering knowledge on the use of Dymista® in Asian patients who receive Dymista® for the first time in routine clinical practice; Patient's demographic;

Anamnestic background including:

• allergic and other comorbidities

• allergic conjunctivitis

• polysensitization

• current symptoms

• previous treatments of allergic rhinitis

• usage of current asthma reliever medication

• family history of allergy

B) Secondary Objective:

• Response to therapy with Dymista® nasal spray in routine clinical practice.

• Quality of sleep (by VAS)

• Troublesomeness in daily activities (by VAS)

• Patient's assessment about the regular use of Dymista®

• Patients opinion about continuation of Dymista® treatment after end of the observational period ;

Related Conditions & MeSH terms

• Allergic Rhinitis
• Rhinitis
• Rhinitis, Allergic

• NCT number: NCT05158972
• Study type: Observational
• Source: Viatris Inc.
• Status: Completed
• Start date: October 27, 2021
• Completion date: October 24, 2023